EMCURENSEEmcure Pharmaceuticals LimitedMinimalNeutral
Announced Wed, 6 May · 18:24 IST

Newspaper Publication of Audited Financial Results of the Company for the quarter and year ended March 31, 2026

EMCURE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.4%1-day move
₹1669.00
prior close
₹1677.40
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.2-1.2-0.9-1.2-1.4+0.3-0.7-0.8+0.2+1.5+2.8+3.1+10.5
Up moveDown movePending
AI summary

Emcure Pharmaceuticals has published extracts of its audited financial results for the quarter and financial year ended March 31, 2026, in Financial Express and Loksatta newspapers on May 6, 2026. This filing is pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates listed companies to publish their quarterly and annual financial results in newspapers. The actual financial figures (revenue, profit, EPS, etc.) are not included in this cover letter filing; they would appear in the published newspaper extracts. The results have also been uploaded on the company's website at www.emcure.com.

Likely market impact

This is a routine compliance filing confirming that Emcure has fulfilled its regulatory obligation to disseminate quarterly and annual financial results through newspaper publication. The actual stock impact will depend on the financial numbers published separately, which are not available in this filing.